हिंदी में पढ़ें

pharmaceutical

South Korea's pharmaceutical, biotechnology exports surge 55% in H1

South Korea's pharmaceutical, biotechnology exports surge 55% in H1

Sat, Jun 29, 2024

In the first six months of the year, the country exported 4.5 trillion won ($3.26 billion) worth of pharmaceutical and biotechnologies, up 55 per cent from 2.9 trillion won (about $2.09 billion) for the same period last year, according to the data from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

Dr Reddy's Laborataries signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection

Dr Reddy's Laborataries signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection

Wed, Jun 12, 2024

Dr Reddy's Laboratories Inc and US-based Ingenus Pharmaceuticals, LLC have entered into license agreement to commercialise cancer-treating Cyclophosphamide injection.

Orchid Pharma gets DCGI nod to market antibiotic drug combination

Orchid Pharma gets DCGI nod to market antibiotic drug combination

Thu, Jun 06, 2024

The Drug Controller General of India (DCGI) has granted permission to manufacture and market the finished dosage form of Cefepime and Enmetazobactam as a dry powder injectable, the drug firm said in a statement.

TRENDING NOW

Drug-maker Lupin completes acquisition of two brands from Sanofi

Drug-maker Lupin completes acquisition of two brands from Sanofi

Wed, Jun 05, 2024

Shares of Lupin were trading 3.21 per cent higher at Rs 1,613.45 apiece on the BSE.

Suven Pharma to merge with Cohance Lifesciences

Suven Pharma to merge with Cohance Lifesciences

Thu, Feb 29, 2024

Upon the scheme becoming effective, all shareholders of Cohance will be issued 11 shares of Suven for every 295 shares held in the former, Suven Pharmaceuticals said in a statement.

53 commonly-used medicines fail central drugs control body's tests, 3 found to be spurious

53 commonly-used medicines fail central drugs control body's tests, 3 found to be spurious

Tue, Aug 29, 2023

Among the medicines that failed the government's test include antacids, medicines used to treat fever, antibiotics and many drugs that are commonly available at the neighbourhood chemist store.

Revenue of top domestic pharmaceutical firms to grow by 7-9% in FY24: ICRA

Revenue of top domestic pharmaceutical firms to grow by 7-9% in FY24: ICRA

Tue, Jul 25, 2023

The growth will be supported by an 8-10 per cent expansion in the domestic market and a 6-8 per cent rise in the US market, while revenues from the European and emerging markets are expected to increase by 3-5 per cent and 8-10 per cent, respectively.

Crackdown on pharma companies: Licences of 18 pharmaceutical firms cancelled for manufacturing spurious drugs

Crackdown on pharma companies: Licences of 18 pharmaceutical firms cancelled for manufacturing spurious drugs

Tue, Mar 28, 2023

Central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them. Twenty-six other companies have been issued show cause notices

Domestic pharmaceutical market to reach USD 130 billion by 2030: Eco Survey

Domestic pharmaceutical market to reach USD 130 billion by 2030: Eco Survey

Tue, Jan 31, 2023

The country's pharmaceutical exports achieved a healthy growth of 24 per cent in FY21, driven by COVID-19-induced demand for critical drugs and other supplies made to over 150 countries, said the survey tabled in Parliament on Tuesday.

Panacea Biotec founder and chairman Soshil Kumar Jain dies

Panacea Biotec founder and chairman Soshil Kumar Jain dies

Fri, Oct 07, 2022

Panacea Biotec Ltd founder and chairman Soshil Kumar Jain died on Friday. According to a regulatory filing by the company, Jain (89), who had been admitted to the Medanta Hospital for the last ten days, suffered a cardiac arrest on Friday afternoon.

Lupin share price rose 2.5% after the company received USFDA approval for new drug to treat overactive bladder

Lupin share price rose 2.5% after the company received USFDA approval for new drug to treat overactive bladder

Fri, Sep 30, 2022

Lupin share price jumped nearly 2.5% to Rs 682 per share levels on the BSE intraday after the company received USFDA approval for Mirabegron Tablets or Generic Myrbetriq

Cipla business plan: Drug major betting big on digitisation and emerging segments

Cipla business plan: Drug major betting big on digitisation and emerging segments

Sun, Aug 07, 2022

Cipla, the country's third largest drug maker, has 47 manufacturing sites around the world which cater to around 86 markets across the globe.

Rs 150 crore black income detected during raids at multiple business groups in Delhi-NCR

Rs 150 crore black income detected during raids at multiple business groups in Delhi-NCR

Wed, Aug 03, 2022

The CBDT said the search teams also seized documents which showed that there was a practice of referral payment to doctors and clinics without duly recording these in the books of account.

Indian pharma sector emerges as favourite destination for foreign investors, says Health Minister Mansukh Mandaviya

Indian pharma sector emerges as favourite destination for foreign investors, says Health Minister Mansukh Mandaviya

Wed, Apr 27, 2022

Mansukh Mandaviya, on Wednesday, said that the pharmaceutical industry of India has emerged as a favorite destination for foreign investors.

Pharmaceutical Bill to be moved in Rajya Sabha

Pharmaceutical Bill to be moved in Rajya Sabha

Thu, Dec 09, 2021

The Rajya Sabha will consider The National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021 for passing on Thursday amid a faceoff with the opposition, while Defence Minister Rajnath Singh is expected to make a statement on the chopper crash in the House.

Lincoln Pharma is exploring new areas in African, EU & South-East Asian countries: Mahendra Patel, MD

Lincoln Pharma is exploring new areas in African, EU & South-East Asian countries: Mahendra Patel, MD

Wed, Nov 25, 2020

Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd, talks about the sales and export markets, new geographies of expansion, launches of new products and CapEx among others during a candid chat with Zee Business Executive Editor Swati Khandelwal

Govt move to incentivise API exports a big boost for sector, IOL Chemicals Jt MD Vijay Garg tells Anil Singhvi

Govt move to incentivise API exports a big boost for sector, IOL Chemicals Jt MD Vijay Garg tells Anil Singhvi

Tue, Oct 27, 2020

Zee Business’ exclusive news on government's plans to incentivise exports in the API manufacturing was spot on regarding incentives for the domestic API manufacturing segment. In a chat with Managing Editor Anil Singhvi, IOL Chemicals and Pharmaceuticals Limited’s Joint Managing Director Vijay Garg explains what it means for the sector and his company and impact on China

Stocks To Buy Today With Anil Singhvi: Know why Sandeep Jain is bullish on pharma and GTB

Stocks To Buy Today With Anil Singhvi: Know why Sandeep Jain is bullish on pharma and GTB

Tue, Sep 01, 2020

Stocks To Buy Today With Anil Singhvi: In yet another edition of 'GEMS by Jain Sahib' show, market analyst Sandeep Jain brings a stock that has great potential to earn high returns for investors. This stock is from the pharmaceutical sector, a sector that this technical analyst is extremely bullish on

Stocks to Buy: GEMS that put health In your wealth - Sandeep Jain reveals to Anil Singhvi why investors should buy these 2 stocks

Stocks to Buy: GEMS that put health In your wealth - Sandeep Jain reveals to Anil Singhvi why investors should buy these 2 stocks

Tue, Jul 28, 2020

In yet another extremely captivating show on Zee Business, Managing Editor Anil Singhvi has charted an agenda where individual analysts in his panel of experts have been tagged with extremely entertaining nicknames that matches their powerful investing style. Here we look at 'GEMS by Jain Sahib'. Market analyst Sandeep Jain has recommends two stocks

Non-price control medicines price to get reduced

Non-price control medicines price to get reduced

Wed, Nov 27, 2019

Non-price control medicines price to get reduced. Watch this video to know more.

Indian healthcare may grow threefold to $372 billion by 2022: Assocham

Indian healthcare may grow threefold to $372 billion by 2022: Assocham

Sun, Dec 03, 2017

The Indian healthcare market is likely to reach $372 billion by 2022 in a threefold growth in value terms, industry chamber Assocham said on Sunday, citing its latest study on the subject.

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Fri, Jul 28, 2017

Key Highlights 7 drugs represent a total estimated market potential of more than $800 million

Dr Reddy's Laboratories Q4 review: Here's what to expect

Dr Reddy's Laboratories Q4 review: Here's what to expect

Fri, May 12, 2017

In Q3FY17, the company reported consolidated net profit of Rs 492.3 crore, down 15.94% year-on-year compared to Rs 585.7 crore in the corresponding period of the previous year.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x